Esperion Therapeutis.Inc. buy Wolf_of_WS
Summary
This prediction ended on 30.08.23 with a price of €1.46. The BUY prediction by Wolf_of_WS finished with a performance of 12.31%. Wolf_of_WS has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Esperion Therapeutis.Inc. | 2.077% | 2.077% | 20.256% |
iShares Core DAX® | 1.887% | 1.967% | 17.000% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% |
According to Wolf_of_WS what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
In the thread Trading Esperion Therapeutis.Inc.
Stopped prediction by Wolf_of_WS for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
21.09.23
21.09.24
01.10.23
Esperion Therapeutis.Inc.
10.05.23
10.05.24
15.05.23
Esperion Therapeutis.Inc.
11.04.23
11.04.24
15.04.23